Issue 8/2019
Content (9 Articles)
Antidepressant Drugs
Leading Article
Methylene Blue in the Treatment of Neuropsychiatric Disorders
Martin Alda
Headache
Review Article
Neurological and Psychiatric Adverse Effects of Antimicrobials
Madison K. Bangert, Rodrigo Hasbun
Epilepsy
Systematic Review
Branched-Chain Amino Acids and Seizures: A Systematic Review of the Literature
Shaun E. Gruenbaum, Eric C. Chen, Mani Ratnesh Singh Sandhu, Ketaki Deshpande, Roni Dhaher, Denise Hersey, Tore Eid
Antiepileptic Drugs
Systematic Review
Intravenous Brivaracetam in the Treatment of Status Epilepticus: A Systematic Review
Francesco Brigo, Simona Lattanzi, Raffaele Nardone, Eugen Trinka
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
Tina deVries, Angela Dentiste, Clifford Di Lea, Vincent Pichette, David Jacobs
Subarachnoid Hemorrhage
Original Research Article
Temporal Trends and Predictors of Drug Utilization and Outcomes in First-Ever Stroke Patients: A Population-Based Study Using the Singapore Stroke Registry
See-Hwee Yeo, Wai-Ping Yau
Zonisamide
Original Research Article
Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy
John M. Wild, Philip E. M. Smith, Carlo Knupp
Polyneuropathy
Adis Drug Evaluation
Immune Globulin Subcutaneous (Human) 20% (Hizentra®): A Review in Chronic Inflammatory Demyelinating Polyneuropathy
Yvette N. Lamb, Yahiya Y. Syed, Sohita Dhillon
Bumetanide
Correction
Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy
Zeinab Gharaylou, Abbas Tafakhori, Elmira Agah, Vajiheh Aghamollaii, Abbas Kebriaeezadeh, Mahmoudreza Hadjighassem